Linking metabolic reprogramming to therapy resistance in cancer-Reference-Cited by-同舟云学术

Linking metabolic reprogramming to therapy resistance in cancer

Published:2017-08 Issue:1 Volume:1868 Page:1-6
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Morandi Andrea,Indraccolo Stefano

Funder

Fondazione Umberto Veronesi

Associazione Italiana Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference59 articles.

1. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers;Sakai;Nature,2008

2. Mechanisms and strategies to overcome multiple drug resistance in cancer;Ozben;FEBS Lett.,2006

3. Understanding the Warburg effect: the metabolic requirements of cell proliferation;Vander Heiden;Science,2009

4. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia;Xu;Cancer Res.,2005

5. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation;Wagner;Cell Commun. Signal.,2015

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROCK2 increases drug resistance in acute myeloid leukemia via metabolic reprogramming and MAPK/PI3K/AKT signaling;International Immunopharmacology;2024-10

2. CENPA promotes glutamine metabolism and tumor progression by up-regulating SLC38A1 in endometrial cancer;Cellular Signalling;2024-05

3. Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence;Science Advances;2024-04-05

4. Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer;Lung Cancer;2024-04

5. USP46 enhances tamoxifen resistance in breast cancer cells by stabilizing PTBP1 to facilitate glycolysis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-03